[A look into the neighboring discipline: eHealth in oncology].

Ein Blick in die Nachbardisziplin: eHealth in der Onkologie.

Artificial intelligence Digital health applications Digital tools Digital transformation Telemedicine

Journal

Chirurgie (Heidelberg, Germany)

ISSN: 2731-698X

Titre abrégé: Chirurgie (Heidelb)

Pays: Germany

ID NLM: 9918383081906676

Informations de publication

Date de publication:
10 May 2024

Historique:

accepted: 09 04 2024

medline: 10 5 2024

pubmed: 10 5 2024

entrez: 10 5 2024

Statut: aheadofprint

Résumé

Digitalization is dramatically changing the entire healthcare system. Keywords such as artificial intelligence, electronic patient files (ePA), electronic prescriptions (eRp), telemedicine, wearables, augmented reality and digital health applications (DiGA) represent the digital transformation that is already taking place. Digital becomes real! This article outlines the state of research and development, current plans and ongoing uses of digital tools in oncology in the first half of 2024. The possibilities for using artificial intelligence and the use of DiGAs in oncology are presented in more detail in this overview according to their stage of development as they already show a noticeable benefit in oncology. Die Digitalisierung verändert das gesamte Gesundheitssystem dramatisch. Schlagworte wie künstliche Intelligenz, elektronische Patientenakte (ePA), elektronisches Rezept (eRp), Telemedizin, Wearables, Augmented Reality oder digitale Gesundheitsanwendungen (DiGA) stehen für die bereits stattfindende digitale Transformation. Digital wird real! Der folgende Überblick skizziert den Stand der Forschung und Entwicklung, aktuelle Planungen und bereits laufende Nutzungen digitaler Tools in der Onkologie in der ersten Hälfte des Jahres 2024. Die Möglichkeiten der Nutzung von künstlicher Intelligenz und der Einsatz von DiGAs in der Onkologie werden in dieser Übersicht entsprechend ihrem Entwicklungsstand etwas ausführlicher dargestellt, da sie in der Onkologie bereits einen erkennbaren Nutzen zeigen.

Autres résumés

Type: Publisher (ger)

Die Digitalisierung verändert das gesamte Gesundheitssystem dramatisch. Schlagworte wie künstliche Intelligenz, elektronische Patientenakte (ePA), elektronisches Rezept (eRp), Telemedizin, Wearables, Augmented Reality oder digitale Gesundheitsanwendungen (DiGA) stehen für die bereits stattfindende digitale Transformation. Digital wird real! Der folgende Überblick skizziert den Stand der Forschung und Entwicklung, aktuelle Planungen und bereits laufende Nutzungen digitaler Tools in der Onkologie in der ersten Hälfte des Jahres 2024. Die Möglichkeiten der Nutzung von künstlicher Intelligenz und der Einsatz von DiGAs in der Onkologie werden in dieser Übersicht entsprechend ihrem Entwicklungsstand etwas ausführlicher dargestellt, da sie in der Onkologie bereits einen erkennbaren Nutzen zeigen.

Identifiants

DOI: 10.1007/s00104-024-02089-8 PMID: 38727743

pubmed: 38727743

doi: 10.1007/s00104-024-02089-8

pii: 10.1007/s00104-024-02089-8

doi:

Types de publication

English Abstract Journal Article Review

Langues

ger

Sous-ensembles de citation

Informations de copyright

Références

Cellina M et al (2022) Artificial intelligence in lung cancer imaging: unfolding the future. Diagnostics 12(11):2644. https://doi.org/10.3390/diagnostics12112644

doi: 10.3390/diagnostics12112644 pubmed: 36359485 pmcid: 9689810

Esteva A, Kuprel B, Novoa R et al (2017) Dermatologist-level classification of skin cancer with deep neural networks. Nature 542:115–118. https://doi.org/10.1038/nature21056

doi: 10.1038/nature21056 pubmed: 28117445 pmcid: 8382232

Chen S et al (2023) Deep learning-based pathology signature could reveal lymph node status and act as a novel prognostic marker across multiple cancer types. Br J Cancer 129(1):46–53. https://doi.org/10.1038/s41416-023-02262-6

doi: 10.1038/s41416-023-02262-6 pubmed: 37137998 pmcid: 10307798

Bulten W, Kartasalo K, Chen P‑HC et al (2022) Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge. Nat Med 28:154–163. https://doi.org/10.1038/s41591-021-01620-2

doi: 10.1038/s41591-021-01620-2 pubmed: 35027755 pmcid: 8799467

Nam JG et al (2023) AI improves nodule detection on chest radiographs in a health screening population: a randomized controlled trial. Radiology. https://doi.org/10.1148/radiol.221894

doi: 10.1148/radiol.221894 pubmed: 37367443 pmcid: 10245183

Chaunzwa TL et al (2021) Deep learning classification of lung cancer histology using CT images. Sci Rep 11:5471. https://doi.org/10.1038/s41598-021-84630-x

doi: 10.1038/s41598-021-84630-x pubmed: 33727623 pmcid: 7943565

Baek S, He Y, Allen BG et al (2019) Deep segmentation networks predict survival of non-small cell lung cancer. Sci Rep 9:17286. https://doi.org/10.1038/s41598-019-53461-2

doi: 10.1038/s41598-019-53461-2 pubmed: 31754135 pmcid: 6872742

Robles-Medranda C et al (2023) Artificial intelligence for diagnosing neoplasia on digital cholangioscopy: development and multicenter validation of a convolutional neural network model. Endoscopy 55(8):719–727. https://doi.org/10.1055/a-2034-3803

doi: 10.1055/a-2034-3803 pubmed: 36781156 pmcid: 10374349

Yamada M, Saito Y, Imaoka H et al (2019) Development of a real-time endoscopic image diagnosis support system using deep learning technology in colonoscopy. Sci Rep 9:14465. https://doi.org/10.1038/s41598-019-50567-5

doi: 10.1038/s41598-019-50567-5 pubmed: 31594962 pmcid: 6783454

Saldanha OL, Loeffler CML, Niehues JM et al (2023) Self-supervised attention-based deep learning for pan-cancer mutation prediction from histopathology. Npj Precis Onc 7:35. https://doi.org/10.1038/s41698-023-00365-0

doi: 10.1038/s41698-023-00365-0

Pao JJ, Biggs M, Duncan D et al (2023) Predicting EGFR mutational status from pathology images using a real-world dataset. Sci Rep 13:4404. https://doi.org/10.1038/s41598-023-31284-6

doi: 10.1038/s41598-023-31284-6 pubmed: 36927889 pmcid: 10020556

Jeppesen M et al (2023) Accurate prediction of protein assembly structure by combining AlphaFold and symmetrical docking. Nat Commun 14(1):8283. https://doi.org/10.1038/s41467-023-43681-6

doi: 10.1038/s41467-023-43681-6 pubmed: 38092742 pmcid: 10719378

Cai Y et al (2023) Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy. Front Oncol 12:1054231. https://doi.org/10.3389/fonc.2022.1054231

doi: 10.3389/fonc.2022.1054231 pubmed: 36698417 pmcid: 9868469

Jumper J et al (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596:583–589

doi: 10.1038/s41586-021-03819-2 pubmed: 34265844 pmcid: 8371605

Baek M et al (2021) Accurate prediction of protein structures and interactions using a three-track neural network. Science 373:871–876

doi: 10.1126/science.abj8754 pubmed: 34282049 pmcid: 7612213

Lin Z et al (2023) Evolutionary-scale prediction of atomic level protein structure with a language model. Science 379:1123–1130

doi: 10.1126/science.ade2574 pubmed: 36927031

Manz CR et al (2023) Long-term effect of machine learning–triggered behavioral nudges on serious illness conversations and end-of-life outcomes among patients with cancer. JAMA Oncol 9(3):414–418. https://doi.org/10.1001/jamaoncol.2022.6303

doi: 10.1001/jamaoncol.2022.6303 pubmed: 36633868 pmcid: 9857721

Placido D et al (2023) A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories. Nat Med 29(5):1113–1122. https://doi.org/10.1038/s41591-023-02332-5

doi: 10.1038/s41591-023-02332-5 pubmed: 37156936 pmcid: 10202814

Garriga R et al (2022) Machine learning model to predict mental health crises from electronic health records. Nat Med 28(6):1240–1248. https://doi.org/10.1038/s41591-022-01811-5

doi: 10.1038/s41591-022-01811-5 pubmed: 35577964 pmcid: 9205775

Ayers JW et al (2023) Comparing physician and artificial intelligence chatbot responses to patient questions posted to a public social media forum. JAMA Intern Med 183(6):589–596. https://doi.org/10.1001/jamainternmed.2023.1838

doi: 10.1001/jamainternmed.2023.1838 pubmed: 37115527 pmcid: 10148230

Embedding patient-reported outcomes at the heart of artificial intelligence health-care technologies. https://www.thelancet.com/journals/landig/article/PIIS2589-7500 (22)00252-7/fulltext

Govindaraj R et al (2023) Assessing patient-reported outcomes in routine cancer clinical care using electronic administration and telehealth technologies: realist synthesis of potential mechanisms for improving health outcomes. J Med Internet Res 25:e48483. https://doi.org/10.2196/48483

doi: 10.2196/48483 pubmed: 38015606 pmcid: 10716761

Klier K et al (2023) Corrected QT interval (QTc) diagnostic app for the oncological routine: development study. JMIR Cardio 7:e48096. https://doi.org/10.2196/48096

doi: 10.2196/48096 pubmed: 37695655 pmcid: 10520775

Harbeck N et al (2023) Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2-metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO‑B WSG PreCycle trial. Ann Oncol 34(8):660–669. https://doi.org/10.1016/j.annonc.2023.05.003

doi: 10.1016/j.annonc.2023.05.003 pubmed: 37201751

Schunn FA et al (2023) Oncologic treatment support via a dedicated mobile app: a prospective feasibility evaluation (OPTIMISE-1). Strahlenther Onkol. https://doi.org/10.1007/s00066-023-02166-7

doi: 10.1007/s00066-023-02166-7 pubmed: 37947806

Changing cancer mindsets: a randomized controlled feasibility and efficacy trial. https://pubmed.ncbi.nlm.nih.gov/37529924/

Kaidar-Person O et al (2023) Evaluating the ability of an artificial-intelligence cloud-based platform designed to provide information prior to locoregional therapy for breast cancer in improving patient’s satisfaction with therapy: the CINDERELLA trial. PLoS ONE 18(8):e289365. https://doi.org/10.1371/journal.pone.0289365

doi: 10.1371/journal.pone.0289365 pubmed: 37535564 pmcid: 10399739

Adam R et al (2021) Can-pain—a digital intervention to optimise cancer pain control in the community: development and feasibility testing. Support Care Cancer 29(2):759–769. https://doi.org/10.1007/s00520-020-05510-0

doi: 10.1007/s00520-020-05510-0 pubmed: 32468132

Digital therapeutic to improve cancer-related well-being: a pilot randomized controlled trial. https://pubmed.ncbi.nlm.nih.gov/37321673/

Trained artificial intelligence (AI) for predicting treatment termination based on patient observations in advanced breast cancer. https://aacrjournals.org/cancerres/article/83/5_Supplement/P6-03-08/718143/Abstract-P6-03-08-Trained-Artificial-Intelligence

One million cancer treatment months (OMCAT). https://clinicaltrials.gov/study/NCT04531995

Optimization of a technology-supported physical activity promotion intervention for breast cancer survivors: results from Fit2Thrive. https://pubmed.ncbi.nlm.nih.gov/34812521/

Saesen R et al (2023) Defining the role of real-world data in cancer clinical research: the position of the European organisation for research and treatment of cancer. Eur J Cancer 186:52–61. https://doi.org/10.1016/j.ejca.2023.03.013

doi: 10.1016/j.ejca.2023.03.013 pubmed: 37030077

www.pink-brustkrebs.de

Spahrkäs SS et al (2020) Beating cancer-related fatigue with the Untire mobile app: results from a waiting-list randomized controlled trial. Psychooncology. https://doi.org/10.1002/pon.5492

doi: 10.1002/pon.5492 pubmed: 33393199 pmcid: 7756868